You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(01558.HK)擬向廣東東陽光生物製劑增資4.86億元
格隆匯 04-02 16:49

格隆匯4月2日丨東陽光藥(01558.HK)發佈公告,2020年4月2日,為了進一步擴大公司產能及為後續儲備產品的上市提供產能保障,公司擬以自有資金向其全資子公司廣東東陽光生物製劑有限公司增資人民幣4.86億元,用於生物製劑公司生產經營建設。本次增資完成後,生物製劑公司註冊資本將變更為人民幣5.3億元。

公司控股公司廣東東陽光科技控股股份有限公司於2020年4月2日召開母公司第十屆董事會第二十二次會議並審議通過了《關於對控股子公司增資的議案》,同意由公司向生物製劑公司進行增資。

就本次對全資子公司的增資,資金主要用於生物製劑公司生產設施建設,為公司擴大產能及後續儲備產品上市提供產能保障,符合公司發展規劃和業務發展需要,有利於提高公司的競爭力,不存在損害公司及其全體股東利益。增資對公司合併財務報表不構成影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account